Correspondence 0001193125-23-213418 from RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772) (RAPT)
RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772)
Date: Aug. 15, 2023 · CIK: 0001673772 · Accession: 0001193125-23-213418
AI Filing Summary & Sentiment
File numbers found in text: 333-273910
Letter
RAPT THERAPEUTICS, INC.
561 Eccles Avenue
South San Francisco, California 94080
(650) 489-9000
August 15, 2023
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: RAPT Therapeutics, Inc.
Registration Statement on Form S-3
Filed August 11, 2023
File No. 333-273910
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-273910) (the “Registration Statement”) to become effective on Thursday, August 17, 2023, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Courtney Tygesson of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney Tygesson of Cooley LLP, counsel to the Registrant, at (312)881-6680, or in her absence Christina Roupas of Cooley LLP at (312) 881-6670.
Very truly yours,
RAPT THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP RAPT THERAPEUTICS, INC. 561 Eccles Avenue South San Francisco, California 94080 (650) 489-9000 August 15, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: RAPT Therapeutics, Inc. Registration Statement on Form S-3 Filed August 11, 2023 File No. 333-273910 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-273910) (the “Registration Statement”) to become effective on Thursday, August 17, 2023, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Courtney Tygesson of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Courtney Tygesson of Cooley LLP, counsel to the Registrant, at (312)881-6680, or in her absence Christina Roupas of Cooley LLP at (312) 881-6670. Very truly yours, RAPT THERAPEUTICS, INC. By: /s/ Brian Wong Name: Brian Wong Title: President and Chief Executive Officer cc: Michael Listgarten, General Counsel, RAPT Therapeutics, Inc. Courtney Tygesson, Cooley LLP Christina Roupas, Cooley LLP